Investigational drug 1 1.3 NSCLC, non-small cell lung cancer; SQ, squamous.
. Subsequent chemotherapies received by squamous and non-squamous NSCLC patients after treatment discontinuation.
Non-SQ NSCLC, N=76
SQ NSCLC, N=35 Data are shown with 95% CIs unless otherwise stated. CI, confidence interval; DCR, disease control rate; DOR, duration of response; NA, not available; NR, not reached; ORR, overall response rate; OS, overall survival; PD-L1, programmed death-ligand 1; PFS, progression-free survival; SQ, squamous. Interstitial lung disease
